Russell Lewis
TitleCited byYear
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases
DP Kontoyiannis, MS Lionakis, RE Lewis, G Chamilos, M Healy, ...
The Journal of infectious diseases 191 (8), 1350-1360, 2005
6182005
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ...
haematologica 91 (7), 986-989, 2006
5402006
Antifungal drug resistance of pathogenic fungi
DP Kontoyiannis, RE Lewis
The Lancet 359 (9312), 1135-1144, 2002
4752002
Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis
G Chamilos, RE Lewis, DP Kontoyiannis
Clinical Infectious Diseases 47 (4), 503-509, 2008
4352008
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study
N Singh, AP Limaye, G Forrest, N Safdar, P Munoz, K Pursell, S Houston, ...
Transplantation 81 (3), 320-326, 2006
3452006
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic …
DP Kontoyiannis, R Hachem, RE Lewis, GA Rivero, HA Torres, J Thornby, ...
Cancer 98 (2), 292-299, 2003
3192003
Pharmacology of systemic antifungal agents
ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes
Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006
3072006
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos, EM Marom, RE Lewis, MS Lionakis, DP Kontoyiannis
Clinical Infectious Diseases 41 (1), 60-66, 2005
2882005
Canal irrigation and local social organization [and comments and reply]
RC Hunt, E Hunt, GM Ahmed, JW Bennett, RK Cleek, PEB Coy, TF Glick, ...
Current Anthropology 17 (3), 389-411, 1976
2621976
Current concepts in antifungal pharmacology
RE Lewis
Mayo Clinic Proceedings 86 (8), 805-817, 2011
2612011
Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods
ME Klepser, EJ Ernst, RE Lewis, ME Ernst, MA Pfaller
Antimicrobial agents and chemotherapy 42 (5), 1207-1212, 1998
2611998
Mucormycosis caused by unusual mucormycetes, non-Rhizopus,-Mucor, and-Lichtheimia species
MZR Gomes, RE Lewis, DP Kontoyiannis
Clinical Microbiology Reviews 24 (2), 411-445, 2011
2492011
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007) Stable incidence but changing epidemiology of a still frequently lethal …
NV Sipsas, RE Lewis, J Tarrand, R Hachem, KV Rolston, II Raad, ...
Cancer 115 (20), 4745-4752, 2009
2432009
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ...
Clinical microbiology and infection 24, e1-e38, 2018
2272018
Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management
DP Kontoyiannis, RE Lewis
Infectious Disease Clinics 20 (3), 581-607, 2006
2242006
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity
NP Wiederhold, DP Kontoyiannis, J Chi, RA Prince, VH Tam, RE Lewis
The Journal of infectious diseases 190 (8), 1464-1471, 2004
2122004
How I treat mucormycosis
DP Kontoyiannis, RE Lewis
Blood 118 (5), 1216-1224, 2011
2112011
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes
M Stanzani, E Orciuolo, R Lewis, DP Kontoyiannis, SLR Martins, ...
Blood 105 (6), 2258-2265, 2005
1972005
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam, AN Schilling, G Vo, S Kabbara, AL Kwa, NP Wiederhold, ...
Antimicrobial agents and chemotherapy 49 (9), 3624-3630, 2005
1832005
Comparison of Etest, chequerboard dilution and time–kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species
RE Lewis, DJ Diekema, SA Messer, MA Pfaller, ME Klepser
Journal of Antimicrobial Chemotherapy 49 (2), 345-351, 2002
1732002
The system can't perform the operation now. Try again later.
Articles 1–20